Biosensors International Group is a Singapore-based medical device company focused on the design, development and commercialization of innovative medical devices for the diagnosis and treatment of cardiovascular diseases. Founded in 1990, the company has become one of the global players in the medical device industry.Biosensors International Group's products are used in the treatment of coronary artery disease, peripheral artery disease and other vascular diseases. The company's product portfolio includes drug-eluting stents, bare metal stents and diagnostic catheters. Biosensors International Group's flagship product is the BioMatrix drug-eluting stent for the treatment of coronary artery disease.The company places emphasis on research and development and has invested heavily in this area over the years. Biosensors International Group has multiple R&D centers around the world, including Singapore, Switzerland and the United States. The company's research and development efforts have resulted in the development of several innovative medical devices that have received regulatory approval in various countries.Biosensors International Group has global operations in Asia, Europe and America. The company has been recognized for its innovative technologies and has received several awards for its products and technologies. The company is committed to improving patient outcomes and is continually striving to develop new and innovative medical devices to help improve the lives of patients with cardiovascular disease.